| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |